Decibel Therapeutics clinical trials
Acquired by Regeneron Pharmaceuticals, Sep 25, 2023 · source ↗
The registry lists 1 studies whose lead sponsor is Decibel Therapeutics. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 6, 2023.
Before and after it joined Regeneron Pharmaceuticals
- First submitted before Decibel Therapeutics became part of Regeneron Pharmaceuticals
- 1
- First submitted after Decibel Therapeutics became part of Regeneron Pharmaceuticals
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Decibel Therapeutics1 study
Something wrong with this grouping? Tell us on the Regeneron Pharmaceuticals page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Regeneron Pharmaceuticals studies →
- Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer TreatmentCompletedNCT04262336Phase 1
Sponsor listed in the registry: Decibel Therapeutics · First submitted before Decibel Therapeutics became part of Regeneron Pharmaceuticals